JCO Oncology Practice is a premier peer-reviewed journal published by Lippincott Williams & Wilkins, specializing in the intersection of oncology and health policy. Established as a vital resource since 2020, this journal serves as a platform for the dissemination of innovative research, policy analysis, and clinical practice advancements aimed at enhancing cancer care. With its impressive impact factor and recognition in the top quartile (Q1) across multiple categories including Health Policy and Oncology, JCO Oncology Practice ranks #3 in Oncology Nursing and consistently shares cutting-edge insights that drive improvements within the field. The journal is accessible to a broad audience through its open access options, ensuring that vital knowledge reaches practitioners, researchers, and students alike. By prioritizing the latest evidence-based practices and addressing contemporary challenges in cancer treatment, JCO Oncology Practice plays an essential role in shaping the future of oncology practice and policy in the United States and beyond.

JAMIA Open is an open-access journal dedicated to advancing the field of health informatics, published by Oxford University Press. Since its inception in 2018, the journal has provided a platform for novel research, reviews, and case studies that bridge the gap between healthcare and information technology. With an impressive impact factor and a current classification in the Q2 quartile for Health Informatics, JAMIA Open has established itself as a vital resource for researchers and practitioners alike, facilitating the dissemination of innovative findings that contribute to the evolution of healthcare systems. Based in the United States, the journal is committed to providing free and equitable access to high-quality research, thus promoting a collaborative and informed approach to tackling pressing health issues. As it continues to grow and evolve, JAMIA Open remains a cornerstone in the landscape of health informatics, appealing to a diverse audience of researchers, professionals, and students looking to inspire change in their fields.

CANCER, published by Wiley, stands as a pivotal journal in the field of oncology and cancer research, boasting an impressive impact factor and consistently dynamic growth since its inception in 1948. With an ISSN of 0008-543X and an E-ISSN of 1097-0142, this esteemed journal is recognized for its rigorous peer-reviewed articles, making significant contributions to the understanding of cancer biology, treatment modalities, and clinical practices. CANCER holds a distinguished position in the academic community, securing its placement in the Q1 category for both cancer research and oncology, and ranks within the top percentiles on Scopus, indicating its high impact and relevance. The journal is particularly beneficial for researchers, professionals, and students seeking to stay abreast of the latest advancements in cancer science. By addressing essential research questions and providing pathways for new therapies, CANCER continues to play a crucial role in shaping the future of oncology and improving patient outcomes.

Journal of the Egyptian National Cancer Institute, published by SPRINGER, serves as a vital platform for disseminating innovative research in the field of oncology and cancer research. With both ISSN 1110-0362 and E-ISSN 2589-0409, this Open Access journal has been committed to making significant contributions to the scientific community since its inception in 2005. Operating from its base in Egypt, it has established itself as an important resource for researchers, practitioners, and students alike, offering insights into contemporary issues and advancements in cancer care. Recognized in the 2023 category quartiles as Q3 in Cancer Research and Q3 in Oncology, the journal is positioned to impact the ongoing discourse in cancer treatment strategies and health policy. As it continues to publish peer-reviewed articles through available Open Access avenues, the Journal of the Egyptian National Cancer Institute remains dedicated to enhancing the knowledge base and collaborative efforts within the global cancer research community.

Medical Oncology, published by Humana Press Inc, stands as a significant contributor to the field of oncology, with its long-standing commitment to disseminating research and clinical findings relevant to the treatment and management of cancer. Established in 1994 and continuing through 2024, this journal publishes insightful articles that reflect the latest advancements in cancer research, hematology, and related medical fields. With an evolving impact factor and remarkable categorizations, including Q3 in Cancer Research and Q2 in both Hematology and Oncology, Medical Oncology serves as a pivotal resource for healthcare providers, researchers, and students dedicated to improving cancer outcomes. Although it does not offer open access, the journal is widely recognized for its rigorous peer-review process and high-quality publications, making it an essential platform for sharing innovative research and critical reviews in oncology.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, published by Springer, is a prestigious peer-reviewed journal dedicated to advancing the fields of cancer research and clinical oncology. With an impact factor reflecting its significance within the academic community, the journal operates under a rigorous quality standard and offers a wealth of knowledge spanning from 1979 and continuing through 2025. With its comprehensive scope, it encompasses a wide array of topics including novel therapeutic strategies, clinical trials, and cutting-edge research methodologies, making it an essential resource for researchers, practitioners, and students alike. The journal’s category quartiles highlight its competitive edge, ranking Q2 in Cancer Research and Q1 in Medicine (miscellaneous) as of 2023. This positioning underscores its role at the forefront of oncology discourse. Through this journal, contributors and readers alike engage with impactful research that informs clinical practices and enhances patient care in oncology. Access to the journal’s content, although not open access, ensures curated and high-quality insights available to the academic and professional community.

BMC Primary Care is a leading peer-reviewed journal published by BMC that provides a vital platform for the dissemination of research and developments in the field of primary care. Established in 2022 as an open access journal, it allows for greater accessibility and visibility of research findings. Operating from the United Kingdom, BMC Primary Care has rapidly assumed an esteemed position within the academic community, currently ranked in the Q1 category for both Family Practice and Medicine (miscellaneous) based on 2023 metrics. With a Scopus rank of #9 out of 56 in Family Practice, positioned in the 84th percentile, this journal serves as an essential resource for researchers, healthcare practitioners, and students seeking to enhance their understanding of primary care dynamics. Through a commitment to high-quality research, BMC Primary Care aims to foster innovation and effective practices that ultimately improve patient care and health outcomes.

JMIR Research Protocols, published by JMIR PUBLICATIONS, INC, is a leading open-access journal that has been at the forefront of advancing research methodologies since its inception in 2012. With its ISSN 1929-0748, this journal is dedicated to providing a platform for the publication of innovative study protocols in the field of medicine, ensuring rigorous peer review and promoting transparency in research practices. Based in Canada, the journal has steadily gained recognition, currently holding a prominent position in the Q3 category of Medicine (Miscellaneous), with an impressive Scopus rank of #211 out of 636, placing it in the 66th percentile of its field. Researchers and professionals will find that JMIR Research Protocols not only supports the open sharing of knowledge but also enhances collaboration among the scientific community. Its open-access policy ensures broader dissemination of research findings, making it an essential resource for anyone interested in the evolving landscape of medical research methodologies.

JOURNAL OF MEDICAL INTERNET RESEARCH, published by JMIR PUBLICATIONS, INC, stands as a pivotal resource in the field of Health Informatics, with an esteemed ranking of #7 out of 138 in the Scopus database, placing it in the top 95th percentile. Since its inception in 1999, this Open Access journal has been committed to disseminating high-quality, peer-reviewed research that explores the intersection of healthcare and internet technologies. With its headquarters in Toronto, Canada, the journal encompasses a broad range of topics, including eHealth, telemedicine, and mobile health innovations. The impact factor and its Q1 quartile ranking highlight the journal's significant influence and prevalence in advancing the understanding of digital health landscapes. Researchers, professionals, and students alike benefit from its valuable insights, making the JOURNAL OF MEDICAL INTERNET RESEARCH an essential tool for fostering informed practices and policy-making in the rapidly evolving domain of health informatics.

The Lancet Respiratory Medicine, published by Elsevier in the United Kingdom, is a premier journal dedicated to the field of pulmonary and respiratory medicine. With its impressive impact factor and a prestigious ranking of #1 out of 155 in its category as of 2023, it holds a remarkable position in advancing research and clinical practices in respiratory health. The journal invites original research, reviews, and clinical studies that aim to propel the understanding of respiratory diseases, fostering innovations in treatment and management strategies. Operating under a Q1 category in Scopus rankings, it is an essential platform for researchers, healthcare professionals, and students who are committed to enhancing patient care and advancing knowledge in this crucial area of medicine. The Lancet Respiratory Medicine remains a vital resource for the latest findings and discussions shaping the future of respiratory health.